| Vol. 17.12 – 29 March, 2023 |
| |
|
|
| Investigators developed single-cell split barcoding (SISBAR) that allowed clonal tracking of single-cell transcriptomes across stages in an in vitro model of human ventral midbrain-hindbrain differentiation. [Cell Stem Cell] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers explored plasma acid sphingomyelinase (ASM) as a circulating factor that accelerated neuropathological features in Alzheimer’s disease by exposing young APP/PS1 mice to the blood of mice overexpressing ASM, through parabiotic surgery. [Nature Communications] |
|
|
|
| Scientists reported Insulin-like Growth Factor-Binding Protein 5 (IGFBP5), a ligand for Receptor tyrosine kinase like Orphan Receptor 1 (ROR1), as a promising target for glioblastoma stem-like cell invasion. [Nature Communications] |
|
|
|
| Researchers investigated the adaptive behavior of glioblastoma stem cells under different cholesterol supplies by conducting in vitro loss-of-function genetic and pharmacologic assays to evaluate the effect of Sterol Regulatory Element-Binding Protein 2 (SREBP2). [Neuro-Oncology] |
|
|
|
| Through transcriptome sequencing, in vivo experiments, and in vitro experiments, investigators found that fatostatin induces ferroptosis by inhibiting the AKT/mTORC1/GPX4 signaling pathway in glioblastoma. [Cell Death & Disease] |
|
|
|
| The authors demonstrated that dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) elicited αSynuclein (αSyn) accumulation and hampered αSyn clearance in primary neurons. [npj Parkinson’s Disease] |
|
|
|
| Scientists presented a unique culturing method, transcriptomic profiles of quail’s brain cells, and a custom-tailored AAV1 for the transduction of quail neurons in vitro and in vivo. [Communications Biology] |
|
|
|
| Investigators showed that succinic semialdehyde dehydrogenase (SSADH) was upregulated in glioma tissues irrespective of the histological grade and its expression sustains glioma cell motility. [Neurotherapeutics] |
|
|
|
| Researchers focused on the ROS/TXNIP/NLRP3 pathway to determine whether chrysophanol regulates oxidative stress and neuroinflammation. [Inflammopharmacology] |
|
|
|
|
| | Investigators discuss the involvement of astrocytic α7nAChRs in the instigation and potentiation of early amyloid-β pathology and explore their potential as a target for future reactive astrocyte-based therapeutics and imaging biomarkers in Alzheimer’s disease. [Nature Reviews Neurology] |
|
|
|
| The authors cover recent discoveries on axonal translation as a critical mechanism for neuronal maintenance and survival. They focus on two RNA-binding proteins whose mutations cause amyotrophic lateral sclerosis and frontotemporal dementia. [Neuron] |
|
|
|
|
| Cyclerion Therapeutics, Inc. announced that the US FDA has granted orphan drug designation to zagociguat for the treatment of mitochondrial diseases. [Cycleroin Therpeutics, Inc.] |
|
|
|
|
| April 17 – 19, 2023 Freiburg im Breisgau, Germany |
|
|
|
|
|
| Technical University of Denmark – Kongens Lyngby, Denmark |
|
|
|
| University of Amsterdam – Amsterdam, Netherlands |
|
|
|
| Columbia University – New York City, New York, United States |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
|